Milliman Healthcare Inflation Guard ETF

Milliman Healthcare Inflation Guard ETF

MHIG
Milliman Healthcare Inflation Guard ETFUS flagNew York Stock Exchange Arca
- -
USD
- -
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
Sector
Financial Services
Industry
Asset Management - Bonds
Address
71 S. Wacker Dr., Floor 31 Wilmington DE United States of America 60606
IPO Date
Apr 21, 2026
Business
Milliman Healthcare Inflation Guard ETF (MHIG) is an actively managed exchange-traded fund that seeks to deliver returns generally equivalent to the United States healthcare cost inflation rate over time, as measured by Milliman Health Trend Guidelines. The fund is advised by Milliman Financial Risk Management LLC (Milliman FRM), with strategy informed by Milliman’s actuarial analysis and quantitative modeling to assess relationships among equities, fixed income, and commodities relative to healthcare inflation. MHIG first trades on the NYSE Arca and is designed to hedge against rising U.S. healthcare costs by investing in a diversified mix of assets. Main products and services - Active ETF management and advisory services: Milliman FRM provides investment strategy, risk management, and portfolio construction for MHIG, including asset allocation and monthly rebalancing using its proprietary quantitative framework. - Equity investments: U.S.-listed common stocks and ADRs of healthcare sector companies and entities involved in the U.S. healthcare supply chain. - Fixed income: Corporate bonds issued by healthcare-related companies to complement equity exposure and manage duration and credit risk. - Hedging instruments: Commodities, Treasury Inflation-Protected Securities (TIPS), and Treasury bonds selected to hedge against U.S. healthcare cost inflation as indicated by Milliman’s models. - Currency and market exposure: Domestic U.S. investments with a focus on developed markets exposure within the healthcare ecosystem. - Indexing and analytics support: Use of Milliman actuarial tools and the Quantitative Model to project inflation trajectories and inform portfolio allocations. Latest major company changes - Product launches and listing: Milliman launches MHIG alongside a sister product MHIP, both targeting protection against rising healthcare costs; MHIG began trading on NYSE Arca in 2026, marking a formal expansion of Milliman FRM’s ETF offerings in the healthcare inflation space. These launches consolidate approximately two years of incubation and conversion of prior healthcare investment solutions into exchange-traded formats. MHIG’s inception and listing are accompanied by the establishment of an anchored framework using Milliman’s Health Trend Guidelines and the 351 Exchange mechanism to transition assets from a predecessor managed account. These developments reflect a strategic shift toward scalable, liquid vehicles for health cost hedging. Additional context - Industry and segments: Financial services, specialized ETF products, risk-managed investment strategies; focus on healthcare sector equities, fixed income, and inflation hedging instruments. - Target markets and customers: Institutional and individual investors seeking hedge exposure to U.S. healthcare cost inflation, including retirement and long-duration healthcare cost risk management needs. - Geographic operations: United States-based fund with investments primarily in U.S.-listed securities and U.S. healthcare supply-chain issuers; portfolio strategy leverages Milliman’s U.S.-centric healthcare data and trend analysis. - Founding year and headquarters: Milliman, Inc. operates as the sponsor and adviser, with its historical base in the United States; the precise year of founding for Milliman FRM aligns with Milliman’s broader corporate history, and the MHIG product is a continuation of Milliman’s actuarial and risk-management capabilities. - Subsidiaries/ownership: MHIG is managed by Milliman FRM on behalf of Milliman, Inc., with the broader Milliman organization providing actuarial and analytical resources underpinning the ETF’s strategy.